TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35877214

Group type: EXPERIMENTAL
Intervention: Smart Drain Coaxial tube (SDC group)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard chest tube (ST group)
Number of subjects: 98
Study: 34313633

Group type: EXPERIMENTAL
Intervention: Enhanced vasodilation treatment (EVT) based on renin‐angiotensin blockade and/or amlodipine
Number of subjects: 81

Group type: COMPARATOR
Intervention: Reduced vasodilation treatment (RVT) based on nonvasodilating β‐blockade (metoprolol)
Number of subjects: 81
Study: 32887596

Group type: EXPERIMENTAL
Intervention: Freire's Adult Education Model (FAEM) intervention
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 132
Study: 36065593

Group type: EXPERIMENTAL
Intervention: Penalised maximum likelihood estimate (MLE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditional maximum likelihood estimate (MLE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional primary analysis
Number of subjects: 0
Study: 33657403

Group type: EXPERIMENTAL
Intervention: Rivaroxaban monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination therapy with rivaroxaban and an antiplatelet agent
Number of subjects: 0
Study: 36318919

Group type: EXPERIMENTAL
Intervention: Partial meal replacement plan (2 meal replacement shakes plus a healthy meal for 3 months)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Partial meal replacement plan
Number of subjects: 153
Study: 32293463

Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy (HFNT) during pulmonary rehabilitation (PR)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Non-high-flow nasal therapy (non-HFNT) during pulmonary rehabilitation (PR)
Number of subjects: 44
Study: 34906660

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) delivered via mobile phone messaging for 14 days, twice daily messages
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no messages)
Number of subjects: 90
Study: 32633899

Group type: EXPERIMENTAL
Intervention: Lumbopelvic tilt motor training task
Number of subjects: 30

Group type: COMPARATOR
Intervention: Finger abduction control task
Number of subjects: 30
Study: 33338430

Group type: EXPERIMENTAL
Intervention: Multisensory-motor training to distinguish mirror letters (e.g., 'b' vs 'd') for 7.5 hours combined with post-training sleep.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-training sleep enhancement of learning consolidation.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Causal approach targeting mirror invariance inhibition.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized controlled trials.
Number of subjects: 0
Study: 33047586

Group type: EXPERIMENTAL
Intervention: Routine mesoappendixectomy, restrictive strategy for abdominal drainage, and postoperative antibiotic prevention (main group)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Mesoappendixectomy only in case of necrotic changes (control group)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Routine mesoappendixectomy (main group)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 127
Study: 36000551

Group type: EXPERIMENTAL
Intervention: Ginseng, Lilii Bulbus, and Poria (GLP) supplementation
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 32845021

Group type: EXPERIMENTAL
Intervention: Multinutrient supplements (fish oil and multivitamin)
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: Multinutrient supplements and food‐related behavioral activation therapy (F‐BA)
Number of subjects: 682

Group type: COMPARATOR
Intervention: Placebos
Number of subjects: 682

Group type: COMPARATOR
Intervention: Placebos and food‐related behavioral activation therapy (F‐BA)
Number of subjects: 682
Study: 34883184

Group type: EXPERIMENTAL
Intervention: Chiglitazar
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 81
Study: 34908185

Group type: EXPERIMENTAL
Intervention: Conventional balanced occlusion (CBO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lingualised balanced occlusion (LBO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Masticatory performance with increased cycles
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Second masticatory evaluation session
Number of subjects: 30
Study: 36410405

Group type: EXPERIMENTAL
Intervention: Canine-assisted intervention (CAI) consisting of 35-min weekly sessions over 6 weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study: 32627064

Group type: EXPERIMENTAL
Intervention: Tramadol combined with butorphanol
Number of subjects: 126

Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 126
Study: 34393051

Group type: EXPERIMENTAL
Intervention: Stroboscopic vision (SV)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Eyes open (EO)
Number of subjects: 60
Study: 34378511

Group type: EXPERIMENTAL
Intervention: Mitomycin
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 82

Group type: COMPARATOR
Intervention: Saline (no treatment)
Number of subjects: 82
Study: 32660566

Group type: EXPERIMENTAL
Intervention: Long-term (6 days) supplementation of amaranth concentrate derived dietary NO3- (±400 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 34301224

Group type: EXPERIMENTAL
Intervention: VR + CBT (N=68)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: VR + CR (N=63)
Number of subjects: 131
Study: 35510755

Group type: EXPERIMENTAL
Intervention: Statin use (low intensity, moderate intensity, high intensity)
Number of subjects: 31169

Group type: EXPERIMENTAL
Intervention: Low-intensity statins
Number of subjects: 31169

Group type: EXPERIMENTAL
Intervention: Moderate-intensity statins
Number of subjects: 31169

Group type: EXPERIMENTAL
Intervention: High-intensity statins
Number of subjects: 31169

Group type: COMPARATOR
Intervention: Non-users of statins
Number of subjects: 31169

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 31169
Study: 34881189

Group type: EXPERIMENTAL
Intervention: Context-informed pre-visit planning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard pre-visit planning
Number of subjects: 0
Study: 34259846

Group type: EXPERIMENTAL
Intervention: Video messages on COVID-19 delivered by physicians (3 videos discussing symptoms, case numbers, and social distancing guidelines)
Number of subjects: 20460

Group type: COMPARATOR
Intervention: Control group (3 placebo videos with generic health topics)
Number of subjects: 20460
Study: 34983022

Group type: EXPERIMENTAL
Intervention: Individualized-load power training (IPT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Traditional moderate-load power training (TPT)
Number of subjects: 10
Study: 33089386

Group type: EXPERIMENTAL
Intervention: Lactic acid 30% with ferulic peel 12% (combination peel)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ferulic peel 12% alone (monotherapy)
Number of subjects: 60
Study: 32513252

Group type: EXPERIMENTAL
Intervention: Elbow hemiarthroplasty (EHA)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 44
Study: 33277302

Group type: EXPERIMENTAL
Intervention: AP+MDA
Number of subjects: 11

Group type: COMPARATOR
Intervention: CSII
Number of subjects: 11

Group type: COMPARATOR
Intervention: AP
Number of subjects: 11
Study: 33893867

Group type: EXPERIMENTAL
Intervention: Dynamic 4-grade system for tear film viscosity grading
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normal playback speed
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 0.8-times playback speed
Number of subjects: 34
Study: 32428027

Group type: EXPERIMENTAL
Intervention: Community Score Card (CSC) intervention
Number of subjects: 412

Group type: COMPARATOR
Intervention: Control
Number of subjects: 412
Study: 34951063

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (stationary home trainer)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Stretching (active control)
Number of subjects: 130
Study: 32098219

Group type: EXPERIMENTAL
Intervention: Morning-green tea (MGT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Evening-green tea (EGT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Morning-placebo (MP)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Evening-placebo (EP)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Acute EGCG administration (morning and evening in mice)
Number of subjects: 38
Study: 36200646

Group type: EXPERIMENTAL
Intervention: High‐dose dual‐impregnated antibiotic‐loaded cement (DIAC) including gentamicin and clindamycin
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Low‐dose single‐impregnated gentamicin antibiotic‐loaded cement (SIAC)
Number of subjects: 7000

Group type: EXPERIMENTAL
Intervention: DIAC
Number of subjects: 7000

Group type: COMPARATOR
Intervention: SIAC
Number of subjects: 7000
Study: 32488583

Group type: EXPERIMENTAL
Intervention: Caregiver-mediated telemedicine tools for assessing ASD risk
Number of subjects: 0
Study: 35596958

Group type: EXPERIMENTAL
Intervention: Interventional Embolization
Number of subjects: 144

Group type: COMPARATOR
Intervention: Intracranial Clipping
Number of subjects: 144
Study: 32536106

Group type: EXPERIMENTAL
Intervention: Prefabricated carpometacarpal metacarpophalangeal immobilization splint for 6 weeks
Number of subjects: 63

Group type: COMPARATOR
Intervention: Nonsplint group (oral information about daily activities)
Number of subjects: 63
Study: 36175902

Group type: EXPERIMENTAL
Intervention: Acupotomy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Corticosteroid injection
Number of subjects: 90
Study: 33675139

Group type: EXPERIMENTAL
Intervention: Investigational intervention for Alzheimer's disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical methods for estimating treatment effects
Number of subjects: 0
Study: 32903263

Group type: EXPERIMENTAL
Intervention: Mental fatiguing task (Stroop task)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control task (documentary watching)
Number of subjects: 9
Study: 32040383

Group type: EXPERIMENTAL
Intervention: Brief online interventions for hazardous alcohol use
Number of subjects: 1711

Group type: EXPERIMENTAL
Intervention: High BIDR scores
Number of subjects: 1711

Group type: EXPERIMENTAL
Intervention: Direct measures of alcohol use
Number of subjects: 1711
Study: 33066334

Group type: EXPERIMENTAL
Intervention: Combined nutraceutical containing phytosterols (800 mg) and red yeast rice (5 mg of monacolins), niacin (27 mg), and policosanols (10 mg)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Combined nutraceutical
Number of subjects: 88
Study: 37338553

Group type: EXPERIMENTAL
Intervention: CEUS model
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: EOB-MRI model
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: CEUS-EOB model
Number of subjects: 85
Study: 34333777

Group type: EXPERIMENTAL
Intervention: Care coordination program
Number of subjects: 10614

Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 10614
Study: 34928687

Group type: EXPERIMENTAL
Intervention: Holistic Healing Arts Retreat
Number of subjects: 109
Study: 33649888

Group type: EXPERIMENTAL
Intervention: GetActive (n=41)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: GetActive-Fitbit (n=41)
Number of subjects: 82
Study: 36341846

Group type: EXPERIMENTAL
Intervention: Computerized cognitive training program (UFOVT) for 45 sessions over 2.5 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Computerized games (control group) for 45 sessions over 2.5 years
Number of subjects: 0
Study: 35804370

Group type: EXPERIMENTAL
Intervention: REP + Coaching + Facilitation
Number of subjects: 169

Group type: COMPARATOR
Intervention: REP alone
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: REP + Facilitation
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: REP + Coaching
Number of subjects: 169
Study: 34003662

Group type: EXPERIMENTAL
Intervention: 1-month DAPT
Number of subjects: 509

Group type: COMPARATOR
Intervention: 12-month DAPT
Number of subjects: 509
Study: 32216764

Group type: EXPERIMENTAL
Intervention: Dating SOS intervention (four online sessions)
Number of subjects: 0
Study: 35554955

Group type: EXPERIMENTAL
Intervention: Oral eltrombopag (50 mg daily)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Subcutaneous rhTPO (15000U daily)
Number of subjects: 92
Study: 32867882

Group type: EXPERIMENTAL
Intervention: FDPIR diet that met Dietary Guidelines for Americans (DGA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Typical FDPIR diet
Number of subjects: 13
Study: 35970302

Group type: COMPARATOR
Intervention: Standard of care (SOC; salvage chemoimmunotherapy followed by high-dose therapy with autologous stem cell rescue for responders)
Number of subjects: 0
Study: 32529884

Group type: EXPERIMENTAL
Intervention: Acupuncture at LR3 + KI3
Number of subjects: 29

Group type: COMPARATOR
Intervention: Acupuncture at LR3 and sham location
Number of subjects: 29
Study: 34194041

Group type: EXPERIMENTAL
Intervention: PfSPZ-CVac(PYR) (high dose, 2 × 10^5 PfSPZs)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: PfSPZ-CVac(PYR) (low dose, 5.12 × 10^4 PfSPZs)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: PfSPZ-CVac(CQ)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Infectivity control (homologous CHMI)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Infectivity control (heterologous CHMI)
Number of subjects: 35
Study: 35085303

Group type: EXPERIMENTAL
Intervention: Left hemiplegia (LH)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Right hemiplegia (RH)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Able-bodied (AB)
Number of subjects: 35
Study: 33613861

Group type: EXPERIMENTAL
Intervention: Spironolactone 50 mg daily
Number of subjects: 30
Study: 33211894

Group type: EXPERIMENTAL
Intervention: Screening for amblyogenic risk factors
Number of subjects: 299
Study: 36008120

Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617 and NOX66 combination treatment
Number of subjects: 56
Study: 34115061

Group type: EXPERIMENTAL
Intervention: Osseodensification
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional drilling
Number of subjects: 24
Study: 35067664

Group type: EXPERIMENTAL
Intervention: Marked group (120 eyes)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (120 eyes)
Number of subjects: 240
Study: 33279374

Group type: EXPERIMENTAL
Intervention: Oral olanzapine, risperidone, amisulpride, aripiprazole, or perphenazine (Phase 1)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Oral olanzapine, amisulpride, or clozapine (Phase 2)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Clozapine or another SGAs not previously used (Phase 3B)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Clozapine extended treatment or modified electroconvulsive therapy (Phase 3A)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Naturalistic follow-up phase
Number of subjects: 720
Study: 35640246

Group type: COMPARATOR
Intervention: Postoperative mFOLFOX6 (12 courses of intravenous oxaliplatin [85 mg/m2] with L-leucovorin [200 mg/m2] followed by 5-fluorouracil [400 mg/m2, bolus and 2400 mg/m2, continuous infusion, repeated every 2 weeks])
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Perioperative mFOLFOX6 (six courses each preoperatively and postoperatively)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Perioperative mFOLFOX6
Number of subjects: 48

Group type: COMPARATOR
Intervention: Postoperative mFOLFOX6
Number of subjects: 48
Study: 32778788

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 0
Study: 35041261

Group type: EXPERIMENTAL
Intervention: Eszopiclone
Number of subjects: 96

Group type: COMPARATOR
Intervention: Alprazolam
Number of subjects: 96
Study: 33784467

Group type: EXPERIMENTAL
Intervention: VAULT treatment with brief utterances (four words or fewer)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: VAULT treatment with extended utterances (five words or more)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: CART analysis for treatment responders
Number of subjects: 19
Study: 32093785

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo electroacupuncture (vaccaria seeds)
Number of subjects: 500
Study: 33764102

Group type: EXPERIMENTAL
Intervention: Intranasal amphetamine administration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33486403

Group type: EXPERIMENTAL
Intervention: Home-based palliative approach (HPA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 78
Study: 35912731

Group type: EXPERIMENTAL
Intervention: Cidofovir
Number of subjects: 132

Group type: COMPARATOR
Intervention: Imiquimod
Number of subjects: 132
Study: 33514365

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS)
Number of subjects: 2068

Group type: EXPERIMENTAL
Intervention: Non-alcoholic fatty liver disease (NAFLD)
Number of subjects: 2068

Group type: EXPERIMENTAL
Intervention: EAT volume
Number of subjects: 2068

Group type: COMPARATOR
Intervention: Control group (without MetS)
Number of subjects: 2068
Study: 35324317

Group type: COMPARATOR
Intervention: Laparoscopic standard gastrectomy (LSG)
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Laparoscopic sentinel node navigation surgery (LSNNS)
Number of subjects: 580
Study: 35684105

Group type: EXPERIMENTAL
Intervention: carbonated caffeinated beverage
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: caffeinated beverage
Number of subjects: 24

Group type: COMPARATOR
Intervention: control beverage
Number of subjects: 24
Study: 33589758

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure treatment (systolic BP target of 120 mm Hg)
Number of subjects: 1206

Group type: COMPARATOR
Intervention: Standard blood pressure treatment (systolic BP target of 140 mm Hg)
Number of subjects: 1206
Study: 34301646

Group type: EXPERIMENTAL
Intervention: Dexamethasone alongside standard antiviral treatment with aciclovir
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard treatment alone (control)
Number of subjects: 90
Study: 32273271

Group type: EXPERIMENTAL
Intervention: Glargine U300
Number of subjects: 176

Group type: COMPARATOR
Intervention: Glargine U100
Number of subjects: 176
Study: 616880758

Group type: EXPERIMENTAL
Intervention: Sodium thiosulfate
Number of subjects: 402

Group type: COMPARATOR
Intervention: Control
Number of subjects: 402
Study: 35805647

Group type: EXPERIMENTAL
Intervention: BA + Cr
Number of subjects: 20

Group type: COMPARATOR
Intervention: BA + PL
Number of subjects: 20
Study: 34265791

Group type: EXPERIMENTAL
Intervention: Methadone (2.5 mg/12 h) in combination with morphine
Number of subjects: 41

Group type: COMPARATOR
Intervention: Morphine alone
Number of subjects: 41
Study: 35428993

Group type: EXPERIMENTAL
Intervention: RIG (Radiologically Inserted Gastrostomy)
Number of subjects: 42

Group type: COMPARATOR
Intervention: PEG (Percutaneous Endoscopic Gastrostomy)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: RIG
Number of subjects: 42

Group type: COMPARATOR
Intervention: PEG
Number of subjects: 42
Study: 34721645

Group type: EXPERIMENTAL
Intervention: Foot reflexology (30 minutes, 3 times a week for 4 weeks)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sham foot massage (30 minutes, 3 times a week for 4 weeks)
Number of subjects: 47
Study: 35514234

Group type: EXPERIMENTAL
Intervention: Sex education program (two sessions a week for two weeks, 90 min each)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Sex education program
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study: 33298162

Group type: EXPERIMENTAL
Intervention: Early Stroke Specialist Vocational Rehabilitation (ESSVR) plus usual care (UC)
Number of subjects: 760

Group type: COMPARATOR
Intervention: Usual care (UC) alone
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: ESSVR plus UC
Number of subjects: 760

Group type: COMPARATOR
Intervention: UC alone
Number of subjects: 760
Study: 33259892

Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tucatinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neratinib
Number of subjects: 0
Study: 32331082

Group type: EXPERIMENTAL
Intervention: Lurasidone (40 mg/day or 80 mg/day)
Number of subjects: 271
Study: 36399919

Group type: EXPERIMENTAL
Intervention: Paily Obstetric Forceps (POF)
Number of subjects: 100
Study: 33559971

Group type: EXPERIMENTAL
Intervention: Eurycoma longifolia 600 mg/day for two weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 35661898

Group type: EXPERIMENTAL
Intervention: Targeted home visits by community nurses post treatment administration
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Regular contact with community nursing services
Number of subjects: 25
Study: 33162329

Group type: EXPERIMENTAL
Intervention: BCAA supplementation (pre-exercise: 0.084 g kg−1 BW; during exercise: 0.056 g kg−1 h−1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo solution (non-caloric)
Number of subjects: 18
Study: 32213084

Group type: EXPERIMENTAL
Intervention: Freezing at -20°C
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Freeze-drying
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Freezing at -80°C
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Freezing at -196°C
Number of subjects: 2
Study: 616796775

Group type: EXPERIMENTAL
Intervention: Modified surgical technique for repair of complex vesicovaginal fistulas
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional surgical technique for repair of complex vesicovaginal fistulas
Number of subjects: 29
Study: 36221338

Group type: EXPERIMENTAL
Intervention: Phellinus linteus extract 1000 mg per day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Phellinus linteus extract 2000 mg per day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (2000 mg of dextrin per day)
Number of subjects: 30
Study: 32690741

Group type: EXPERIMENTAL
Intervention: High occupational stress (ERI score >1)
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Severe depression
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Job burn-out
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Working years
Number of subjects: 1400
Study: 34561872

Group type: EXPERIMENTAL
Intervention: High-volume Foley catheter (60 ml) and vaginal misoprostol
Number of subjects: 100